Skip to main content
logo
Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
33.36
+0.41 (1.24%)
Jan 22, 2026, 1:26 PM EST - Market open

Genmab Revenue

Genmab had revenue of $1.02B in the quarter ending September 30, 2025, with 23.34% growth. This brings the company's revenue in the last twelve months to $3.85B, up 29.57% year-over-year. In the year 2024, Genmab had annual revenue of $2.99B with 22.32% growth.

Revenue (ttm)
$3.85B
Revenue Growth
+29.57%
P/S Ratio
5.33
Revenue / Employee
$1,434,416
Employees
2,681
Market Cap
20.51B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.99B545.24M22.32%
Dec 31, 20232.44B358.99M17.23%
Dec 31, 20222.08B796.62M61.88%
Dec 31, 20211.29B-374.23M-22.52%
Dec 31, 20201.66B855.79M106.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Incyte4.81B
BioNTech SE3.70B
Royalty Pharma2.35B
Moderna2.23B
Ionis Pharmaceuticals966.96M
Ascendis Pharma758.59M
Insmed447.02M
BridgeBio Pharma353.78M
Revenue Rankings

GMAB News

More News